{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:09:52Z","timestamp":1783822192406,"version":"3.55.0"},"reference-count":71,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"publisher","award":["e:Med CAPSyS 01ZX1604B, SYMPATH 01ZX1906A, Phage4Cure 16GW0141"],"award-info":[{"award-number":["e:Med CAPSyS 01ZX1604B, SYMPATH 01ZX1906A, Phage4Cure 16GW0141"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"publisher","award":["MAPVAP 16GW0247"],"award-info":[{"award-number":["MAPVAP 16GW0247"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TR84 C6, C9, B1, B6, Z1a, Z1b"],"award-info":[{"award-number":["SFB-TR84 C6, C9, B1, B6, Z1a, Z1b"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010127","name":"J\u00fcrgen Manchot Foundation","doi-asserted-by":"publisher","award":["Stipend"],"award-info":[{"award-number":["Stipend"]}],"id":[{"id":"10.13039\/100010127","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Charit\u00e9 3 R","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Respiratory infections caused by multidrug-resistant Acinetobacter baumannii are difficult to treat and associated with high mortality among critically ill hospitalized patients. Bacteriophages (phages) eliminate pathogens with high host specificity and efficacy. However, the lack of appropriate preclinical experimental models hampers the progress of clinical development of phages as therapeutic agents. Therefore, we tested the efficacy of a purified lytic phage, vB_AbaM_Acibel004, against multidrug-resistant A. baumannii clinical isolate RUH 2037 infection in immunocompetent mice and a human lung tissue model. Sham- and A. baumannii-infected mice received a single-dose of phage or buffer via intratracheal aerosolization. Group-specific differences in bacterial burden, immune and clinical responses were compared. Phage-treated mice not only recovered faster from infection-associated hypothermia but also had lower pulmonary bacterial burden, lower lung permeability, and cytokine release. Histopathological examination revealed less inflammation with unaffected inflammatory cellular recruitment. No phage-specific adverse events were noted. Additionally, the bactericidal effect of the purified phage on A. baumannii was confirmed after single-dose treatment in an ex vivo human lung infection model. Taken together, our data suggest that the investigated phage has significant potential to treat multidrug-resistant A. baumannii infections and further support the development of appropriate methods for preclinical evaluation of antibacterial efficacy of phages.<\/jats:p>","DOI":"10.3390\/v14010033","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T01:03:37Z","timestamp":1640567017000},"page":"33","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Preclinical Assessment of Bacteriophage Therapy against Experimental Acinetobacter baumannii Lung Infection"],"prefix":"10.3390","volume":"14","author":[{"given":"Sandra-Maria","family":"Wienhold","sequence":"first","affiliation":[{"name":"Division of Pulmonary Inflammation, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-3957","authenticated-orcid":false,"given":"Markus C.","family":"Brack","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Inflammation, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"},{"name":"Department of Infectious Diseases and Respiratory Medicine, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1973-3119","authenticated-orcid":false,"given":"Geraldine","family":"Nouailles","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Inflammation, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopinath","family":"Krishnamoorthy","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Inflammation, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6073-9307","authenticated-orcid":false,"given":"Imke H. E.","family":"Korf","sequence":"additional","affiliation":[{"name":"Department of Microorganisms, Leibniz Institute DSMZGerman Collection of Microorganisms and Cell Cultures, 38124 Braunschweig, Germany"},{"name":"Department of Pharmaceutical Biotechnology, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 38124 Braunschweig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Seitz","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biotechnology, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 38124 Braunschweig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wienecke","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biotechnology, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 38124 Braunschweig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Dietert","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathology, Freie Universit\u00e4t Berlin, 14163 Berlin, Germany"},{"name":"Veterinary Centre for Resistance Research, Freie Universit\u00e4t Berlin, 14163 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Gurtner","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathology, Freie Universit\u00e4t Berlin, 14163 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-9993","authenticated-orcid":false,"given":"Olivia","family":"Kershaw","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathology, Freie Universit\u00e4t Berlin, 14163 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4502-0393","authenticated-orcid":false,"given":"Achim D.","family":"Gruber","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathology, Freie Universit\u00e4t Berlin, 14163 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biotechnology, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 38124 Braunschweig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Ziehr","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biotechnology, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 38124 Braunschweig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Rohde","sequence":"additional","affiliation":[{"name":"Central Facility for Microscopy, Helmholtz-Centre for Infection Research (HZI), 38124 Braunschweig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Neudecker","sequence":"additional","affiliation":[{"name":"Department of General, Visceral, Vascular and Thoracic Surgery, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Lienau","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Inflammation, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Suttorp","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Respiratory Medicine, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hippenstiel","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Respiratory Medicine, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas C.","family":"Hocke","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Inflammation, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"},{"name":"Department of Infectious Diseases and Respiratory Medicine, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rohde","sequence":"additional","affiliation":[{"name":"Department of Microorganisms, Leibniz Institute DSMZGerman Collection of Microorganisms and Cell Cultures, 38124 Braunschweig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9787-5633","authenticated-orcid":false,"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Inflammation, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"},{"name":"Department of Infectious Diseases and Respiratory Medicine, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, 10115 Berlin, Germany"},{"name":"German Center for Lung Research (DZL), Partner Site Charit\u00e9, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"ref_1","unstructured":"McCarthy, R. (2021, February 01). Antibiotic resistance: The \u2018Other\u2019 Pandemic Lurking behind COVID-19. Available online: https:\/\/bsac.org.uk\/antibiotic-resistance-the-other-pandemic-lurking-behind-covid-19\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/jac\/dkz074","article-title":"Geographical and temporal variation in the frequency and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bacterial pneumonia: Results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997\u20132016)","volume":"74","author":"Sader","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/CMR.00058-16","article-title":"Clinical and Pathophysiological Overview of Acinetobacter Infections: A Century of Challenges","volume":"30","author":"Wong","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13054-018-2247-y","article-title":"An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: Long-term impact for the ICU and hospital","volume":"22","author":"Lesho","year":"2018","journal-title":"Crit. Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"ref_6","first-page":"288","article-title":"Clinical response and outcome of pneumonia due to multi-drug resistant Acinetobacter baumannii in critically ill patients","volume":"8","author":"Shojaei","year":"2016","journal-title":"Iran. J. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e00915","DOI":"10.1128\/mBio.00915-14","article-title":"Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure","volume":"5","author":"McGann","year":"2014","journal-title":"mBio"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/cir611","article-title":"Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system","volume":"53","author":"Pogue","year":"2011","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_9","unstructured":"World Health Organisation (2021, November 29). Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics, Available online: https:\/\/www.who.int\/medicines\/publications\/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1038\/ncomms14187","article-title":"A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models","volume":"8","author":"Yen","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/AAC.01426-15","article-title":"Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung","volume":"60","author":"Pabary","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e00954-17","DOI":"10.1128\/AAC.00954-17","article-title":"Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s15010-019-01319-0","article-title":"Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient","volume":"47","author":"Law","year":"2019","journal-title":"Infection"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): A randomised, controlled, double-blind phase 1\/2 trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","article-title":"A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy","volume":"34","author":"Wright","year":"2009","journal-title":"Clin. Otolaryngol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Iszatt, J.J., Larcombe, A.N., Chan, H.-K., Stick, S.M., Garratt, L.W., and Kicic, A. (2021). Phage Therapy for Multi-Drug Resistant Respiratory Tract Infections. Viruses, 13.","DOI":"10.3390\/v13091809"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.copbio.2021.03.002","article-title":"Preclinical data and safety assessment of phage therapy in humans","volume":"68","author":"Nale","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/jcm.34.6.1519-1525.1996","article-title":"Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods","volume":"34","author":"Dijkshoorn","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Merabishvili, M., Vandenheuvel, D., Kropinski, A.M., Mast, J., de Vos, D., Verbeken, G., Noben, J.-P., Lavigne, R., Vaneechoutte, M., and Pirnay, J.-P. (2014). Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104853"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1164\/rccm.200505-730OC","article-title":"Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia","volume":"173","author":"Knapp","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1007\/BF01645192","article-title":"Interpretationskriterien der Empfindlichkeitspr\u00fcfung von Ofloxacin mit dem Agardiffusionstest","volume":"14","author":"Grimm","year":"1986","journal-title":"Infection"},{"key":"ref_24","unstructured":"Reimer, L.C., Sarda Carbasse, J., Koblitz, J., Podstawka, A., and Overmann, J. (2021, November 29). Acinetobacter Baumannii Bouvet and Grimont 1986. Available online: https:\/\/bacdive.dsmz.de\/strain\/157916#ref64488."},{"key":"ref_25","first-page":"278","article-title":"Bakteriophagen als Wirkstoffe zur Infektionsbehandlung\u2014Was ist m\u00f6glich?","volume":"8","author":"Dannheim","year":"2020","journal-title":"Pharmakon"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1021\/bi00846a017","article-title":"Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli","volume":"7","author":"Valentine","year":"1968","journal-title":"Biochemistry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13054-018-2224-5","article-title":"Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia","volume":"22","author":"Berger","year":"2018","journal-title":"Crit. Care"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/ALN.0000000000003149","article-title":"Neutralizing Complement C5a Protects Mice with Pneumococcal Pulmonary Sepsis","volume":"132","author":"Kellermann","year":"2020","journal-title":"Anesthesiology"},{"key":"ref_29","first-page":"256","article-title":"Transoral tracheal intubation of rodents using a fiberoptic laryngoscope","volume":"36","author":"Costa","year":"1986","journal-title":"Lab. Anim. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/jac\/dkt131","article-title":"Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia","volume":"68","author":"Doehn","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1165\/rcmb.2017-0337MA","article-title":"Digital Image Analyses on Whole-Lung Slides in Mouse Models of Acute Pneumonia","volume":"58","author":"Dietert","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Dietert, K., Gutbier, B., Wienhold, S.M., Reppe, K., Jiang, X., Yao, L., Chaput, C., Naujoks, J., Brack, M., and Kupke, A. (2017). Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188251"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.micinf.2016.05.002","article-title":"Acinetobacter baumannii and A. pittii clinical isolates lack adherence and cytotoxicity to lung epithelial cells in vitro","volume":"18","author":"Navas","year":"2016","journal-title":"Microbes Infect."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1601953","DOI":"10.1183\/13993003.01953-2016","article-title":"Tyk2 as a target for immune regulation in human viral\/bacterial pneumonia","volume":"50","author":"Berg","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1183\/09031936.00186911","article-title":"Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissue","volume":"40","author":"Szymanski","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_36","unstructured":"Croghan, C., and Egeghy, P.P. (2020, January 22\u201324). Methods of dealing with values below the limit of detection using sas. Presented at the Southeastern SAS User Group, St. Petersburg, FL, USA. Available online: https:\/\/analytics.ncsu.edu\/sesug\/2003\/SD08-Croghan.pdf."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1084\/jem.20110525","article-title":"Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo","volume":"208","author":"Broermann","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1128\/AEM.00526-16","article-title":"In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357","volume":"82","author":"Jeon","year":"2016","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.3389\/fmicb.2017.02659","article-title":"Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice","volume":"8","author":"Hua","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3389\/fmicb.2018.00696","article-title":"Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) Acinetobacter baumannii and Evaluation of Their Therapeutic Efficacy in Vivo","volume":"9","author":"Cha","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmi.2015.12.010","article-title":"Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: High mortality associated with delayed treatment rather than with the degree of neutropenia","volume":"22","author":"Freire","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","article-title":"Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen","volume":"22","author":"Roach","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/649227","article-title":"Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection","volume":"201","author":"Carmody","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1128\/AAC.02388-13","article-title":"Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections","volume":"58","author":"Semler","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/17425247.2017.1252329","article-title":"Inhaled phage therapy: A promising and challenging approach to treat bacterial respiratory infections","volume":"14","author":"Morello","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S2213-2600(13)70072-9","article-title":"Pulmonary drug delivery: From generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges","volume":"1","author":"Ruge","year":"2013","journal-title":"Lancet. Respir. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.addr.2018.08.001","article-title":"Phage therapy for respiratory infections","volume":"133","author":"Chang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/jamp.2008.0701","article-title":"Toward modern inhalational bacteriophage therapy: Nebulization of bacteriophages of Burkholderia cepacia complex","volume":"21","author":"Golshahi","year":"2008","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/phage.2020.0004","article-title":"Natural and Induced Antibodies Against Phages in Humans: Induction Kinetics and Immunogenicity for Structural Proteins of PB1-Related Phages","volume":"1","author":"Majewska","year":"2020","journal-title":"PHAGE"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1128\/IAI.70.1.204-210.2002","article-title":"Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium","volume":"70","author":"Biswas","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"ofaa389","DOI":"10.1093\/ofid\/ofaa389","article-title":"Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States","volume":"7","author":"Aslam","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.01513-06","article-title":"Experimental phage therapy against Staphylococcus aureus in mice","volume":"51","author":"Capparelli","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e00379-19","DOI":"10.1128\/AAC.00379-19","article-title":"Phage Therapy of Pneumonia Is Not Associated with an Overstimulation of the Inflammatory Response Compared to Antibiotic Treatment in Mice","volume":"63","author":"Dufour","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1164\/rccm.201812-2372OC","article-title":"Bacteriophages Improve Outcomes in Experimental Staphylococcus aureus Ventilator-associated Pneumonia","volume":"200","author":"Prazak","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41551-018-0263-5","article-title":"Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections","volume":"2","author":"Agarwal","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1099\/jmm.0.2008\/002873-0","article-title":"Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice","volume":"57","author":"Chhibber","year":"2008","journal-title":"J. Med. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Comeau, A.M., T\u00e9tart, F., Trojet, S.N., Pr\u00e8re, M.-F., and Krisch, H.M. (2007). Phage-Antibiotic Synergy (PAS): Beta-lactam and quinolone antibiotics stimulate virulent phage growth. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000799"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/AEM.02850-14","article-title":"Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): Antibiotics stimulate lytic phage activity","volume":"81","author":"Kamal","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1574-695X.2012.00977.x","article-title":"Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro","volume":"65","author":"Ryan","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e00926-19","DOI":"10.1128\/IAI.00926-19","article-title":"Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies","volume":"88","author":"Mangalea","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Engeman, E., Freyberger, H.R., Corey, B.W., Ward, A.M., He, Y., Nikolich, M.P., Filippov, A.A., Tyner, S.D., and Jacobs, A.C. (2021). Synergistic Killing and Re-Sensitization of Pseudomonas aeruginosa to Antibiotics by Phage-Antibiotic Combination Treatment. Pharmaceuticals, 14.","DOI":"10.3390\/ph14030184"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1080\/22221751.2021.2002671","article-title":"Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture","volume":"10","author":"Wang","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41564-020-00830-7","article-title":"Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials","volume":"6","author":"Forsyth","year":"2021","journal-title":"Nat. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e0046821","DOI":"10.1128\/AEM.00468-21","article-title":"Aminoglycosides Antagonize Bacteriophage Proliferation, Attenuating Phage Suppression of Bacterial Growth, Biofilm Formation, and Antibiotic Resistance","volume":"87","author":"Zuo","year":"2021","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3389\/fmicb.2015.01271","article-title":"On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy","volume":"6","author":"Mattila","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41596-020-0346-0","article-title":"Standardized bacteriophage purification for personalized phage therapy","volume":"15","author":"Luong","year":"2020","journal-title":"Nat. Protoc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1093\/jac\/dku173","article-title":"Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens","volume":"69","author":"Viertel","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_68","unstructured":"Dawson, M. (2021, October 10). Endotoxin Limits for Parenteral Drug Products: BET White Paper. Available online: https:\/\/www.acciusa.com\/pdfs\/whitepapers\/EndotoxinLimits_SeanJH-PR17-012.pdf."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1465-9921-12-125","article-title":"TLR4 signalling in pulmonary stromal cells is critical for inflammation and immunity in the airways","volume":"12","author":"Perros","year":"2011","journal-title":"Respir. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/cid\/cix184","article-title":"The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by \u03b2-Lactams","volume":"64","author":"Dufour","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1038\/s41598-017-08336-9","article-title":"Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages","volume":"7","author":"Clement","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/1\/33\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:52:47Z","timestamp":1760169167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/1\/33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["v14010033"],"URL":"https:\/\/doi.org\/10.3390\/v14010033","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,24]]}}}